Q32 Bio

About:

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Website: https://www.q32bio.com/

Twitter/X: Q32Bio

Top Investors: OrbiMed, Bristol-Myers Squibb, Atlas Venture, Agent Capital, Children’s Hospital Colorado

Description:

Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. Q32 Bio is addressing dysregulation to help patients take back control of their lives in diseases with few to no treatment options, or those diseases where current therapeutics provide inadequate relief. Q32 Bio consists of a team of scientists and industry veterans with strong expertise in immunology. The team has a strong track record of discovering and developing new and innovative therapies.